Gero

📍 Palo Alto, United States🗓 Founded 2018👥 127 employees💰 Last funded Aug 2020
Biotechnology🌐 gero.ai
Website LinkedIn
We are a preclinical stage AI drug discovery company with a mission to eliminate age-related diseases We use AI to build clinically relevant disease phenotypes in real-world human data and identify diseases with shared biology. Then WES-enabled genetic study on these phenotypes allows us to discover novel targets applicable to several indications at once. You can find our publications here: https://gero.ai/publications
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Cyprus
1
Frequently asked questions
Who invested in Gero?
Gero has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Gero last raise funding?
The most recent investment in Gero recorded on gritt.io was in August 2020.
When was Gero founded?
Gero was founded in 2018.
What industry is Gero in?
Gero operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Gero based?
Gero is headquartered in Palo Alto, United States.